Biobusiness: A Strategic Perspective
Gurinder S. Shahi
Lulu.com, Jun 6, 2005 - Business & Economics - 132 pages
Compiled and adapted from completed assignments produced by USC graduate students participating in the inter-disciplinary course, "BioBusiness: A Strategic Perspective" (GSBA-599, Spring 2005), offered by the Marshall School of Business, University of Southern California.
What people are saying - Write a review
We haven't found any reviews in the usual places.
A Viable New Cluster to Help
Major Forces Affecting the Pharmaceutical Industry in
Business Opportunities in the Novel Field of
The BioBusiness Perspective
Challenges to Personalized Medicine
13 ATTACHMENT academia aging agricultural applications benefit billion bio-diesel bio-plastics BioBusiness Biodecap biomolecules biosensor biotech biotech companies blockbuster drugs Building Owner California California’s Bioscience Industries challenges China Chinese CIRM CIRM’s clinical trials competitive conference facility consumers create Daniel Pollack developed countries developed nations dietary disease economic Entity environment Exhibit firms freshwater Functional Foods funding genes genetic testing global Hawaii Human Genome Project identify important incentives increase innovation Institute International investment issues lease Maskus medicine Minimum Requirements nanobiosensors nanosensors nanotechnology nanotube No/low cost normal traveling conditions nutraceuticals Nutrition opportunities outsourcing Paper patent percent pharmaceutical companies pharmaceutical industry pharmacogenomics population potential proposed facility Proposition 71 regulations responsible role San Francisco scientific scientists sector SNPs specific state’s stem cell research strategic Sustainable Development therapeutic therapeutic cloning therapy trend universities